Omega-3 Fatty Acids Supplementation Does Not Affect Serum Lipids in Chronic Hemodialysis Patients

Journal of Renal Nutrition

Volumn 21, Issue 6, 2011, Pages 479-484

  Poulia, Kalliopi Anna ^a   Panagiotakos, Demosthenes B ^b   Tourlede, Eleftheria ^c   Rezou, Athanasia ^a   Stamatiadis, Dimitrios ^a   Boletis, John ^a   Zampelas, Antonis ^c  

^a LAIKO GENERAL HOSPITAL   (Greece)

^b HAROKOPIO UNIVERSITY   (Greece)

^c AGRICULTURAL UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BIOLOGICAL MARKER; C REACTIVE PROTEIN; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID;

ADULT; AGED; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; FEMALE; GREECE; HUMAN; INFLAMMATION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; SINGLE BLIND PROCEDURE;

ADULT; AGED; ALPHA-TOCOPHEROL; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FEMALE; GREECE; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; SINGLE-BLIND METHOD; VITAMIN E;

EID: 80054930665     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2011.01.018     Document Type: Article

References (30)

1. Foley R.N., Parfrey P.S., Sarnak M.J. Clinical epidemiology of cardiovascular disease in chronic renal failure. Am J Kidney Dis 1998, 32(suppl 5):S112-S119.
2. Linder A., Charra B., Sherrard D.J., et al. Accelerated atherosclerosis in prolonged maintenance haemodialysis. N Engl J Med 1974, 290:697-701.
3. Fernández-Reyes M.J., Alvarez-Ude F., Sánchez R., et al. Inflammation and malnutrition as predictors of mortality in patients on hemodialysis. J Nephrol 2002, 15:136-143.
4. Bang H.O., Dyerberg J. Plasma lipids and lipoproteins in Greenland West Coast Eskimos. Acta Med Scand 1972, 192:85-94.
5. Bang H.O., Dyerberg J., Hjorne N. Composition of food by Greenland Eskimos. Acta Med Scand 1976, 200:69-73.
6. Bucher H.C., Hengstler P., Schindler C., et al. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2002, 112:298-304.
7. Koorts A.M., Viljoen M., Kruger M.C. Red blood cell fatty acid profile of chronic renal failure patients receiving maintenance haemodialysis treatment. Prostaglandins Leukot Essent Fatty Acids 2002, 67:13-18.
8. Kutner N.G., Clow P.W., Zhang R., et al. Association of fish intake and survival in a cohort of incident dialysis patients. Am J Kidney Dis 2002, 39:1018-1024.
9. Svensson M., Schmidt E.B., Jorgensen K.A., et al. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study. Nephrol Dial Transplant 2008, 23:2918-2924.
10. Holdt B., Korten G., Knippel M., et al. Increased serum level of total homocysteine in CAPD patients despite fish oil therapy. Perit Dial Int 1996, 16:S246-S249.
11. Fiedler R., Mall M., Wand C., et al. Short term administration of omega-3 PUFA in hemodialysis patients with balanced lipid metabolism. J Ren Nutr 2005, 15:253-256.
12. Rasic-Milutinovic Z., Perunicic G., Pljesa S., et al. Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients. Ren Fail 2007, 29:321-329.
13. Block G., Coyle L.M., Hartman A.M., et al. Revision of dietary analysis software for the Health Habits and History Questionnaire. Am J Epidemiol 1994, 139:1190-1196.
14. Block G., Woods M., Potosky A., et al. Validation of a self-administered diet history questionnaire using multiple diet records. J Clin Epidemiol 1990, 43:1327-1335.
15. Fleis J.L. The Design and the Analysis of Clinical Experiments 1986, John Wiley and Sons, London, United Kingdom, pp 263-271.
16. Lempert K.D., Rogers J.S., Albrink M.J. Effects of dietary fish oil on serum lipids and blood coagulation in peritoneal dialysis patients. Am J Kidney Dis 1988, 11:170-175.
17. Azar R., Dequiedt F., Awada J., et al. Effects of fish oil rich in polyunsaturated fatty acids on hyperlipidemia of hemodialysis patients. Kidney Int Suppl 1989, 27:S239-S242.
18. Dionisio P., Caramello E., Bergia R., et al. Atherogenic risk in patients undergoing regular dialysis treatment: improvement of lipid pattern and lipoproteins by polyunsaturated omega-3 fatty acids. Nephrol Dial Transplant 1994, 9:458.
19. Panzetta O., Cominacini L., Garbin U., et al. Increased susceptibility of LDL to in vitro oxidation in patients on maintenance hemodialysis: effects of fish oil and vitamin E administration. Clin Nephrol 1995, 44:303-309.
20. Bonanome A., Biasia F., De Luca M., et al. A: n-3 fatty acids do not enhance LDL susceptibility to oxidation in hypertriacylglycerolemic hemodialyzed subjects. Am J Clin Nutr 1996, 63:261-266.
21. Fracasso A., Toffoletto P., Landini S., et al. Effect of hypertriglyceridemia correction by omega-3 fatty acids on peritoneal transport in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1993, 13(suppl 2):S437-S439.
22. Yorioka N., Masaki T., Ito T., et al. Lipid-lowering therapy and coagulation/fibrinolysis parameters in patients on peritoneal dialysis. Int J Artif Organs 2000, 23:27-32.
23. Schmitz P.G., McCloud L.K., Reikes S.T., et al. Prophylaxis of hemodialysis graft thrombosis with fish oil: double-blind, randomized, prospective trial. J Am Soc Nephrol 2002, 13:184-190.
24. Iorio L., Saltarelli G., Nacca R.G., et al. Hyperlipidemia in dialysis patients: what treatment?. Miner Electrolyte Metab 1997, 23:311-313.
25. Bowden R.G., Jitomir J., Wilson R.L., et al. Effects of omega-3 fatty acid supplementation on lipid levels in end-stage renal disease patients. J Ren Nutr 2009, 19:259-266.
26. Papakonstantinou E., Ryan D.H., Harris R.B. Dietary fish oil does not protect rats exposed to restraint or sleep deprivation stress. Physiol Behav 2003, 78:759-765.
27. Khajehdehi P. Lipid-lowering effect of polyunsaturated fatty acids in hemodialysis patients. J Ren Nutr 2000, 10:191-195.
28. Ando M., Sanaka T., Nihei H. Eicosapentanoic acid reduces plasma levels of remnant lipoproteins and prevents in vivo peroxidation of LDL in dialysis patients. J Am Soc Nephrol 1999, 10:2177-2184.
29. Rolf N., Tenschert W., Lison A.E. Results of a long-term administration of omega-3 fatty acids in haemodialysis patients with dyslipoproteinaemia. Nephrol Dial Transplant 1990, 5:797-801.
30. Persichetti S., Maggi S., Ponzio R., et al. Effects of omega 3-PUFA on plasma fibrinogen levels in hypertriglyceridemic hemodialysis patients. Minerva Urol Nefrol 1996, 48:137-138.